サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1562202

欧州の迅速検査キット：2030年までの市場予測 - 地域分析 - タイプ、製品、技術、用途、エンドユーザー別

Europe Rapid Test Kit Market Forecast to 2030 - Regional Analysis - by Type, Product, Technology, Application, and End User

出版日
ページ情報
英文 172 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
欧州の迅速検査キット：2030年までの市場予測 - 地域分析 - タイプ、製品、技術、用途、エンドユーザー別
出版日: 2024年07月04日
発行: The Insight Partners
ページ情報: 英文 172 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の迅速検査キット市場は、2022年に52億4,446万米ドルと評価され、2030年には77億6,357万米ドルに達すると予測され、2022年から2030年までのCAGRは5.0％を記録すると推定されます。

メーカーによる戦略的取り組みが欧州の迅速検査キット市場を牽引

迅速検査キット市場のメーカーは、市場での競争力を維持するために、技術革新や製品の発売・承認などの戦略の採用を重視しています。迅速検査キット市場の企業によるこうした戦略的取り組みは、市場全体に利益をもたらします。

2022年、シンガポールを拠点とする診断薬メーカー、アイネックス・イノベートは、アジアの女性・胎児健康分野のパイオニアであり、卵巣がんに対する同社の主力ソリューションであるOvaCis Rapid TestのCEマークを取得しました。2022年末までに、OvaCisは、手術室で良性卵巣嚢腫と悪性卵巣嚢腫を区別する世界初のPOCT（ポイント・オブ・ケア）検査であり、EUと東南アジア市場でデビューする予定です。

2022年1月、OraSure Technologies, Inc.は、ポイントオブケアおよび在宅診断検査、サンプル採取技術の世界的リーダーであり、HIV-1およびHIV-2の口腔スワブベースの在宅検査であるOraQuick HIV Self-Testを欧州市場向けに発売しました。この検査は、英国、フランス、ドイツ、イタリア、スペイン、ポルトガルの欧州6カ国で利用できます。

2021年、CE証明書の発行後、FUJIFILM Europe GmbHはCEマークの適用を認可され、SARS-CoV-2感染診断用の抗原検査キットを発表しました。富士フイルムが利用している技術は、独自の銀増幅イムノクロマトグラフィーと呼ばれるもので、現像する写真を増幅するのと同じ技術に基づいています。

2020年12月、米国食品医薬品局（FDA）は、COVID-19の検出のための家庭での使用を適応とする、事実上ガイド付きのBinaxNOW COVID-19 Ag Card（アボット社製）迅速検査の緊急使用承認（EUA）を発行しました。BinaxNOWは広く普及しており、最も手頃な価格の迅速検査の1つで、数分で結果が得られます。

2020年7月、FDAは、広く販売されているBDベリトール・プラス・システムで使用するための、迅速、ポイントオブケア、SARS-CoV-2診断検査の緊急使用承認（EUA）を与えました。この新しい検査法は、使いやすく携帯性に優れた装置で15分で結果が得られます。この検査は、患者が検査施設にいる間にリアルタイムで結果を提供し、迅速な意思決定を支援することで、COVID-19診断へのアクセスを改善することを目的としています。

欧州の迅速検査キット市場概要

ドイツの糖尿病有病率は著しく増加しています。国際糖尿病連合によると、2021年には6,200万人が糖尿病に罹患しています。さらに、欧州疾病予防管理センターの報告によると、2019年に欧州連合（EU）で8,641件のマラリア症例が登録され、そのうち8,638件（99％以上）が確定診断されました。2022年9月、ドイツは国連合同エイズ計画（UNAIDS）とエイズ、結核、マラリア対策を目的とした13億4,000万米ドル相当の協定に署名し、これにより同国の拠出額は2019年比で30％引き上げられました。さらに、endmalaria.orgの2020年報告書によると、マラリアの制圧と撲滅を目指す資金総額の69％を国際的な資金源が提供しています。マラリアの制圧と撲滅のための総資金は、ドイツからの2億米ドルの拠出を含め、33億米ドルを占めました。このように、ドイツでは糖尿病、エイズ、結核、マラリアなどの感染症の流行が増加しているため、迅速検査キット市場は今後数年で成長する可能性が高いです。

欧州の迅速検査キット市場の収益と2030年までの予測（金額）

欧州の迅速検査キット市場セグメンテーション

欧州の迅速検査キット市場は、タイプ、製品、技術、用途、エンドユーザー、国によって区分されます。タイプ別では、欧州の迅速検査キット市場は迅速抗原検査、迅速抗体検査、その他に区分されます。迅速抗原検査セグメントは2022年に最大の市場シェアを占めました。

製品別では、欧州の迅速検査キット市場は市販用迅速検査キットと業務用迅速検査キットに二分されます。市販用迅速検査キット分野が2022年に大きな市場シェアを占めました。

技術別では、欧州の迅速検査キット市場は、ラテラルフローアッセイ、固相、凝集、イムノスポットアッセイ、細胞成分ベースに区分されます。2022年には、ラテラルフローアッセイセグメンテーションが最大の市場シェアを占めました。

用途別では、欧州の迅速検査キット市場は、血糖値検査、感染症検査、妊娠・不妊検査、心代謝検査、その他に分類されます。血糖値検査セグメントが2022年に最大の市場シェアを占めました。

エンドユーザー別では、欧州の迅速検査キット市場は病院・診療所、在宅医療、診断センター、その他に区分されます。病院・診療所セグメントが2022年に最大の市場シェアを占めました。

国別では、欧州の迅速検査キット市場は、英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。ドイツが2022年の欧州の迅速検査キット市場シェアを独占しました。

F.Hoffmann-La Roche Ltd、Becton Dickinson and Co、ARKRAY Inc、Sysmex Partec GmbH、Fujirebio Europe NV、bioMerieux SA、Cepheid、Meril Life Sciences Pvt Ltd、QIAGEN NV、OraSure Technologies Inc、Guangzhou Wondfo Biotech Co Ltd、Denka Co Ltd.、Abbott Laboratories、Trinity Laboratories Co、Abbott Laboratories、Trinity Biotech Plc、Premier Medical Corp Pvt Ltd、Bio-Rad Laboratories Inc、Hologic Inc、DiaSorin SpA、Beckman Coulter Incは、欧州の迅速検査キット市場で事業を展開する主要企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州の迅速検査キット市場- 主要産業力学

  • 市場促進要因
    • 遺伝性疾患および感染性疾患の有病率の上昇
    • メーカーによる戦略的取り組み
  • 市場抑制要因
    • 結果の正確性に関する不確実性
  • 市場機会
    • PCR技術への嗜好の高まり
  • 今後の動向
    • 迅速抗原検査における技術革新
  • 影響分析

第5章 迅速検査キット市場：欧州市場分析

  • 迅速検査キット市場の収益、2020年～2030年

第6章 欧州の迅速検査キット市場分析：タイプ別

  • 迅速抗原検査
  • 迅速抗体検査
  • その他

第7章 欧州の迅速検査キット市場分析：製品別

  • 市販用迅速検査キット
  • 業務用迅速検査キット

第8章 欧州の迅速検査キット市場分析：技術別

  • ラテラルフローアッセイ
  • 固相
  • 凝集
  • イムノスポットアッセイ
  • 細胞成分ベース

第9章 欧州の迅速検査キット市場分析：用途別

  • 血糖値検査
  • 感染症検査
  • 循環代謝検査
  • 妊娠および不妊検査
  • その他

第10章 欧州の迅速検査キット市場分析：エンドユーザー別

  • 病院および診療所
  • 診断センター
  • 在宅医療
  • その他

第11章 欧州の迅速検査キット市場：国別分析

  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州

第12章 業界情勢

  • 迅速検査キット市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第13章 企業プロファイル

  • F. Hoffmann-La Roche Ltd
  • Becton Dickinson and Co
  • ARKRAY Inc
  • Sysmex Partec GmbH
  • Fujirebio Europe NV
  • bioMerieux SA
  • Cepheid
  • Meril Life Sciences Pvt Ltd
  • QIAGEN NV
  • OraSure Technologies Inc
  • Guangzhou Wondfo Biotech Co Ltd
  • Denka Co Ltd
  • Abbott Laboratories
  • Trinity Biotech Plc
  • Bio-Rad Laboratories Inc
  • Hologic Inc
  • DiaSorin SpA
  • Premier Medical Corp Pvt Ltd
  • Beckman Coulter Inc

第14章 付録

図表

List Of Tables

  • Table 1. Rapid Test Kits Market Segmentation
  • Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 4. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 5. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 6. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 7. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 8. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 9. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 10. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 11. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 12. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 13. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 14. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 15. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 16. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 17. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 18. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 19. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 20. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 21. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 22. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 23. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 24. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 25. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 26. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 27. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 28. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 29. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 30. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 31. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 32. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 33. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 34. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 35. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 36. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 37. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 38. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 39. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
  • Table 40. Recent Organic Growth Strategies in the Rapid Test Kit Market

List Of Figures

  • Figure 1. Rapid Test Kits Market Segmentation, By Country
  • Figure 2. Rapid Test Kits Market: Key Industry Dynamics
  • Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)
  • Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)
  • Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)
  • Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)
  • Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)
  • Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Europe: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 30. Europe: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 31. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 33. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 34. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Growth Strategies in the Rapid Test Kit Market
目次
Product Code: BMIRE00030428

The Europe rapid test kit market was valued at US$ 5,244.46 million in 2022 and is expected to reach US$ 7,763.57 million by 2030; it is estimated to record a CAGR of 5.0% from 2022 to 2030.

Strategic Initiatives by Manufacturers Drive Europe Rapid Test Kit Market

Manufacturers in the rapid test kits market emphasize on the adoption of strategies such as innovations, and product launches and approvals to maintain a competitive edge in the market. Such strategic initiatives by companies in the rapid test kits market benefit the overall market.

In 2022, Singapore-based diagnostics manufacturer INEX Innovate, a pioneer in the women's and fetal health sector in Asia, has received a CE mark for OvaCis Rapid Test, its flagship solution for ovarian cancer. By the end of 2022, OvaCis-a first-of-its-kind point-of-care (POCT) test that distinguishes benign from malignant ovarian cysts in an operating room setting-is expected to make its debut in the EU and Southeast Asian markets.

In January 2022, OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic testing as well as sample collection technologies, launched the OraQuick HIV Self-Test, an oral swab-based in-home test for HIV-1 and HIV-2, for the European market. The test is accessible in six European countries: the UK, France, Germany, Italy, Spain, and Portugal.

In 2021, following the issuance of the CE certificate, FUJIFILM Europe GmbH was authorized to apply the CE mark and introduce an antigen test kit for the diagnosis of SARS-CoV-2 infection. The technique being utilized by Fujifilm is called proprietary silver amplification immunochromatography, and it is based on the same technology that is used to amplify the photos to be developed.

In December 2020, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for a virtually guided BinaxNOW COVID-19 Ag Card (by Abbott) rapid test, indicated for the at-home use for detection of COVID-19. BinaxNOW is a widely distributed and one of the most affordable rapid tests, which provides results in minutes.

In July 2020, the FDA granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor Plus System. The new assay generates results in 15 minutes on an easy-to-use, highly portable instrument. The test was meant to improve access to COVID-19 diagnostics by providing real-time results and aiding quick decision-making while the patient is still in the testing facility.

Europe Rapid Test Kit Market Overview

The prevalence of the diabetes in Germany has been increasing significantly. According to the International Diabetes Federation, in 2021 ~62 million people were having diabetes. Moreover, according to the European Center for Disease Prevention and Control report, 8,641 malarial cases were registered in the European Union (EU) in 2019, of which 8,638 (>99%) were confirmed diagnoses. In September 2022, Germany signed an agreement worth US$ 1.34 billion with The Joint United Nations Programme on HIV/AIDS (UNAIDS) aiming to fight AIDS, tuberculosis, and malaria; with this, the country raised its contribution by 30% compared to 2019. Further, as per the endmalaria.org 2020 report, international sources provided 69% of total funding aiming for malaria control and elimination. The total funding for malaria control and elimination accounted for US$ 3.3 billion, including US$ 0.2 billion contributed by Germany. Thus, the rapid test kits market is likely to grow in Germany in the coming years with the rising prevalence of infectious disease such as diabetes, AIDS, tuberculosis, and malaria.

Europe Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million)

Europe Rapid Test Kit Market Segmentation

The Europe rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the Europe rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022.

In terms of product, the Europe rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022.

By technology, the Europe rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022.

Based on application, the Europe rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022.

In terms of end user, the Europe rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022.

Based on country, the Europe rapid test kit market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe rapid test kit market share in 2022.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Sysmex Partec GmbH, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the Europe rapid test kit market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Rapid Test Kits Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Genetic and Infectious Diseases
    • 4.1.2 Strategic Initiatives by Manufacturers
  • 4.2 Market Restraints
    • 4.2.1 Uncertainties Related to Accuracy of Results
  • 4.3 Market Opportunities
    • 4.3.1 Increasing Preference for PCR Techniques
  • 4.4 Future Trends
    • 4.4.1 Innovations in Rapid Antigen Tests
  • 4.5 Impact Analysis

5. Rapid Test Kits Market - Europe Market Analysis

  • 5.1 Overview
  • 5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030

6. Europe Rapid Test Kits Market Analysis - by Type

  • 6.1 Overview
  • 6.2 Rapid Antigen Testing
    • 6.2.1 Overview
    • 6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Rapid Antibody Testing
    • 6.3.1 Overview
    • 6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Rapid Test Kits Market Analysis - by Product

  • 7.1 Overview
  • 7.2 Over-the-Counter Rapid Testing Kit
    • 7.2.1 Overview
    • 7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Professional Rapid Testing Kit
    • 7.3.1 Overview
    • 7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Rapid Test Kits Market Analysis - by Technology

  • 8.1 Overview
  • 8.2 Lateral Flow Assay
    • 8.2.1 Overview
    • 8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Solid Phase
    • 8.3.1 Overview
    • 8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Agglutination
    • 8.4.1 Overview
    • 8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Immunospot Assay
    • 8.5.1 Overview
    • 8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cellular-Component Based
    • 8.6.1 Overview
    • 8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Rapid Test Kits Market Analysis - by Application

  • 9.1 Overview
  • 9.2 Blood Glucose Testing
    • 9.2.1 Overview
    • 9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Infectious Disease Testing
    • 9.3.1 Overview
    • 9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Cardiometabolic Testing
    • 9.4.1 Overview
    • 9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pregnancy and Fertility
    • 9.5.1 Overview
    • 9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Rapid Test Kits Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospital and Clinics
    • 10.2.1 Overview
    • 10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Home-Care
    • 10.4.1 Overview
    • 10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Rapid Test Kits Market - Country Analysis

  • 11.1 Europe
    • 11.1.1 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 Germany
        • 11.1.1.1.1 Overview
      • 11.1.1.2 Germany: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.1 Germany: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.2.2 Germany: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.2.3 Germany: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.2.4 Germany: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.2.4.1 Germany: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.2.5 Germany: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.3 United Kingdom
        • 11.1.1.3.1 Overview
      • 11.1.1.4 United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.4.2 United Kingdom: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.4.3 United Kingdom: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.4.4 United Kingdom: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.4.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.4.5 United Kingdom: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.5 France
        • 11.1.1.5.1 Overview
      • 11.1.1.6 France: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.6.1 France: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.6.2 France: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.6.3 France: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.6.4 France: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.6.4.1 France: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.6.5 France: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.7 Italy
        • 11.1.1.7.1 Overview
      • 11.1.1.8 Italy: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.8.1 Italy: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.8.2 Italy: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.8.3 Italy: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.8.4 Italy: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.8.4.1 Italy: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.8.5 Italy: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.9 Spain
        • 11.1.1.9.1 Overview
      • 11.1.1.10 Spain: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.10.1 Spain: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.10.2 Spain: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.10.3 Spain: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.10.4 Spain: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.10.4.1 Spain: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.10.5 Spain: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.11 Rest of Europe
        • 11.1.1.11.1 Overview
      • 11.1.1.12 Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.12.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.12.2 Rest of Europe: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.12.3 Rest of Europe: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.12.4 Rest of Europe: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.12.4.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.12.5 Rest of Europe: Rapid Test Kits Market Breakdown, by End User

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Rapid Test Kit Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 F. Hoffmann-La Roche Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Becton Dickinson and Co
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 ARKRAY Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Sysmex Partec GmbH
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Fujirebio Europe NV
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 bioMerieux SA
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Cepheid
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Meril Life Sciences Pvt Ltd
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 QIAGEN NV
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 OraSure Technologies Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Guangzhou Wondfo Biotech Co Ltd
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Denka Co Ltd
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Abbott Laboratories
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Trinity Biotech Plc
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Bio-Rad Laboratories Inc
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 Hologic Inc
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 DiaSorin SpA
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 Premier Medical Corp Pvt Ltd
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments
  • 13.19 Beckman Coulter Inc
    • 13.19.1 Key Facts
    • 13.19.2 Business Description
    • 13.19.3 Products and Services
    • 13.19.4 Financial Overview
    • 13.19.5 SWOT Analysis
    • 13.19.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners